Vinflunine in the treatment of bladder cancer.

about

Treatment of relapsed urothelial bladder cancer with vinflunine: real-world evidence by the Hellenic Genitourinary Cancer Group.A phase II trial of vinflunine as monotherapy or in combination with trastuzumab as first-line treatment of metastatic breast cancer.

P2860

Q36947812-48FE609D-20E7-47C2-9268-0DA1BDBED630 Q42944291-4D50B38E-E2E5-46A9-8660-3BEB5D456120

P2860

Vinflunine in the treatment of bladder cancer.

Item

http://www.wikidata.org/entity/Q42183149

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年学术文章

@wuu

2008年学术文章

@zh-cn

2008年学术文章

@zh-hans

2008年学术文章

@zh-my

2008年学术文章

@zh-sg

2008年學術文章

@yue

2008年學術文章

@zh

2008年學術文章

@zh-hant

name

Vinflunine in the treatment of bladder cancer.

@en

Vinflunine in the treatment of bladder cancer.

@nl

type

Item

label

Vinflunine in the treatment of bladder cancer.

@en

Vinflunine in the treatment of bladder cancer.

@nl

prefLabel

Vinflunine in the treatment of bladder cancer.

@en

Vinflunine in the treatment of bladder cancer.

@nl

P1476

Vinflunine in the treatment of bladder cancer.

@en

P2093

Maria De Santis

http://www.w3.org/2001/XMLSchema#string

Mark Bachner

http://www.w3.org/2001/XMLSchema#string

P2860

Global cancer statistics, 2002

Gemcitabine and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer: results of a large, randomized, multinational, multicenter, phase III study

Anti-vascular effects of vinflunine in the MAC 15A transplantable adenocarcinoma model

Neoadjuvant chemotherapy in invasive bladder cancer: update of a systematic review and meta-analysis of individual patient data advanced bladder cancer (ABC) meta-analysis collaboration.

Adjuvant chemotherapy in invasive bladder cancer: a systematic review and meta-analysis of individual patient data Advanced Bladder Cancer (ABC) Meta-analysis Collaboration.

Single agent 2',2'-difluorodeoxycytidine in the treatment of metastatic urothelial carcinoma: a phase II study.

Phase II trial of pyrazoloacridine as second-line therapy for patients with unresectable or metastatic transitional cell carcinoma.

Docetaxel and ifosfamide as second line treatment for patients with advanced or metastatic urothelial cancer after failure of platinum chemotherapy: a phase 2 study.

Paclitaxel and gemcitabine chemotherapy for advanced transitional-cell carcinoma of the urothelial tract: a phase II trial of the Minnie pearl cancer research network.

Chemotherapy with an every-2-week regimen of gemcitabine and paclitaxel in patients with transitional cell carcinoma who have received prior cisplatin-based therapy.

P304

1243-1253

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/TCRM.S3384

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2008-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19337431

http://www.w3.org/2001/XMLSchema#string

P932

2643105

http://www.w3.org/2001/XMLSchema#string

Vinflunine in the treatment of bladder cancer.

about

P2860

P2860

Vinflunine in the treatment of bladder cancer.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932